Peptides and antibodies for treatment of rheumatoid arthritis

Details Peptides and antibodies for treatment of rheumatoid arthritis Peptides and antibodies for treatment of rheumatoid arthritis

C - Chemistry, Metallurgy

07

K

C07K 7/04 (2006.01) A61K 38/04 (2006.01) A61K 39/395 (2006.01) C07K 5/04 (2006.01) C07K 14/81 (2006.01) C07K 16/38 (2006.01) C07K 16/42 (2006.01) C07K 16/44 (2006.01)

Patent

CA 2123694

2123694 9311153 PCTABS00022 A synthetic peptide of not more than 20 amino acid residues or analogue thereof comprising a thiol-active cysteine residue and at least two positively charged amino acid residues situated on (but not necessarily adjacent to) the N-terminal side, on (but not necessarily adjacent to) the C-terminal side or on (but not necessarily adjacent to) both the N- and C-terminal sides of the thiol active cysteine for use in therapy.

Affiliated with

Also associated with

Rating

Peptides and antibodies for treatment of rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides and antibodies for treatment of rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides and antibodies for treatment of rheumatoid arthritis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1894801